HeMemics Biotechnologies
Latest round
- Seed
Last raised
- Dec 2019
Total raised
- $2.5M
Investors
- 1
About HeMemics Biotechnologies
HeMemics Biotechnologies, Inc.HeMemics Biotechnologies, Inc. focuses on the development of innovative biosensor technologies for various applications.HeMemics Biotechnologies, Inc. specializes in advanced graphene-based biosensors designed for rapid and accurate detection across various applications, including biodefense, agriculture, drug testing, and healthcare diagnostics. Their core products, the HemBox™ and HemChip® Reader Biochip, enable users to conduct on-field testing for biotoxins, herbicides, and drugs of abuse, providing actionable results from a single sample in a matter of minutes. The technology primarily serves military personnel, agricultural professionals, healthcare providers, and individuals undergoing drug testing, ensuring that end-users receive reliable and timely data.HeMemics Biotechnologies generates revenue through direct sales of its biosensor products, including flagship offerings such as the HemBox™ and HemChip® Reader Biochip. The company operates on a business-to-business (B2B) model, engaging with governmental agencies, military organizations, agricultural sectors, and healthcare facilities to provide its solutions. Transactions are structured as direct sales agreements, where clients purchase these devices for their operational needs, ensuring a continuous revenue stream from both initial sales and potential follow-up purchases for consumables or additional units.In March 2025, HeMemics Biotechnologies, Inc. Plans for future growth include the design and launch of new products, which are expected to enhance their existing biosensor technology. Additionally, HeMemics aims to expand its market presence in new geographic regions, with a particular focus on increasing sales in Europe and Asia by the end of 2025.
Who invested in HeMemics Biotechnologies
1 investor across 1 round
See all investors in HeMemics Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 11, 2019
Amount
$2.5M
Investors
Questions about HeMemics Biotechnologies
Who invested in HeMemics Biotechnologies?
HeMemics Biotechnologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HeMemics Biotechnologies raised?
HeMemics Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HeMemics Biotechnologies last raise money?
HeMemics Biotechnologies's most recent round on record is a Seed, in Dec 2019.
What does HeMemics Biotechnologies do?
HeMemics Biotechnologies is a medical devices & equipment company.
Where is HeMemics Biotechnologies headquartered?
HeMemics Biotechnologies is headquartered in Gaithersburg, US.
Which VCs invest in companies like HeMemics Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at HeMemics Biotechnologies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like HeMemics Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.